Advertisement
Correspondence| Volume 238, P188-190, July 2019

Download started.

Ok

Risk of unexpected uterine Cancer in women undergoing myomectomy: A population-based study

Published:March 20, 2019DOI:https://doi.org/10.1016/j.ejogrb.2019.03.021
Risk of unexpected uterine Cancer in women undergoing myomectomy: A population-based study
Previous ArticleMast cell involvement in human cervical ripening
Next ArticleCystic hygroma and micromelic lower limbs: First-trimester sonographic markers of campomelic dysplasia
      Up to 70% of American women develop uterine fibroids (benign smooth muscle tumors) by age 49 [
      • Hartmann K.E.
      • Fonnesbeck C.
      • Surawicz T.
      • Krishnaswami S.
      • Andrews J.C.
      • Wilson J.E.
      • et al.
      Management of uterine fibroids. Comparative Effectiveness Review No. 195.
      Agency for Healthcare Research and Quality, Rockville, MD2017https://doi.org/10.23970/AHRQEPCCER195
      ]. Myomectomy, surgical removal of fibroids while preserving the uterus, offers a treatment option for women who desire future fertility [
      • Hartmann K.E.
      • Fonnesbeck C.
      • Surawicz T.
      • Krishnaswami S.
      • Andrews J.C.
      • Wilson J.E.
      • et al.
      Management of uterine fibroids. Comparative Effectiveness Review No. 195.
      Agency for Healthcare Research and Quality, Rockville, MD2017https://doi.org/10.23970/AHRQEPCCER195
      ]. Although a common gynecologic procedure, myomectomy is not appropriate for patients with suspected or known cancer. Yet fibroids may present with similar symptoms as uterine sarcomas, and there is heightened concern about unrecognized uterine cancer since the U.S. Food and Drug Administration issued safety warnings against power morcellation of uterine tissues [
      • U.S. Food and Drug Administration
      FDA updated assessment of the use of laparoscopic power morcellators to treat uterine fibroids.
      Silver Spring, MD2017
      ]. However, data on the risk of unexpected uterine cancer specifically for women undergoing myomectomy are limited, as prior research has centered on hysterectomies (surgical removal of the uterus). We addressed this important gap using a large population-based sample.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Obstetrics and Gynecology and Reproductive Biology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Hartmann K.E.
        • Fonnesbeck C.
        • Surawicz T.
        • Krishnaswami S.
        • Andrews J.C.
        • Wilson J.E.
        • et al.
        Management of uterine fibroids. Comparative Effectiveness Review No. 195.
        Agency for Healthcare Research and Quality, Rockville, MD2017https://doi.org/10.23970/AHRQEPCCER195 (AHRQ Publication No. 17(18)-EHC028-EF. https://effectivehealthcare.ahrq.gov/topics/uterine-fibroids/research-2017)
        View in Article
        • U.S. Food and Drug Administration
        FDA updated assessment of the use of laparoscopic power morcellators to treat uterine fibroids.
        Silver Spring, MD2017 (Available at: https://www.fda.gov/downloads/MedicalDevices/ProductsandMedicalProcedures/SurgeryandLifeSupport/UCM584539.pdf. Accessed August 14, 2018)
        View in Article
        • Bean E.M.
        • Cutner A.
        • Holland T.
        • Vashisht A.
        • Jurkovic D.
        • Saridogan E.
        Laparoscopic myomectomy: A single-center retrospective review of 514 patients.
        J Minim Invasive Gynecol. 2017; 24: 485-493
        View in Article
        • Brohl A.S.
        • Li L.
        • Andikyan V.
        • Običan S.G.
        • Cioffi A.
        • Hao K.
        • et al.
        Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma.
        Oncologist. 2015; 20: 433-439
        View in Article
        • Sizzi O.
        • Manganaro L.
        • Rossetti A.
        • Saldari M.
        • Florio G.
        • Loddo A.
        • et al.
        Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations.
        Eur J Obstet Gynecol Reprod Biol. 2018; 220: 30-38
        View in Article

      Article info

      Publication history

      Published online: March 20, 2019
      Received: December 20, 2018

      Identification

      DOI: https://doi.org/10.1016/j.ejogrb.2019.03.021

      Copyright

      © 2019 Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX